Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sibylle C Mellinghoff

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|May 12, 2026
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AMLCarolin S Joisten, Sibylle C Mellinghoff, Danila Seidel, et al.
Blood Advances|January 2, 2025
Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysisTim Richardson, Daniel Schütte, Guido Kobbe, et al.
Jac-Antimicrobial Resistance|April 5, 2024
Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centresJule Rutz, Jan-Hendrik Naendrup, Caroline Bruns, et al.
Mycoses|March 12, 2025
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed-EQUAL) Candida Score for the Management of Candidaemia in Children and NeonatesAbhijit M Bal, Zoi Dorothea Pana, Fabianne Carlesse, et al.
Mycoses|November 27, 2019
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope<sup>®</sup> registry and from the literatureJannik Stemler, Jon Salmanton-García, Danila Seidel, et al.
The Journal of Infection|December 18, 2021
T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment optionSibylle C Mellinghoff, Martin Thelen, Christiane Bruns, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2026
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancerMichael Sandherr, Enrico Schalk, Werner J Heinz, et al.
Mycoses|March 17, 2025
Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment OptionSibylle C Mellinghoff, Martin Thelen, Michael von Bergwelt-Baildon, et al.
Leukemia|December 23, 2021
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Leonie Mayer, et al.
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|May 12, 2026
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AMLCarolin S Joisten, Sibylle C Mellinghoff, Danila Seidel, et al.
Blood Advances|January 2, 2025
Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysisTim Richardson, Daniel Schütte, Guido Kobbe, et al.
Jac-Antimicrobial Resistance|April 5, 2024
Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centresJule Rutz, Jan-Hendrik Naendrup, Caroline Bruns, et al.
Mycoses|March 12, 2025
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed-EQUAL) Candida Score for the Management of Candidaemia in Children and NeonatesAbhijit M Bal, Zoi Dorothea Pana, Fabianne Carlesse, et al.
Mycoses|November 27, 2019
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope<sup>®</sup> registry and from the literatureJannik Stemler, Jon Salmanton-García, Danila Seidel, et al.
The Journal of Infection|December 18, 2021
T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment optionSibylle C Mellinghoff, Martin Thelen, Christiane Bruns, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2026
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancerMichael Sandherr, Enrico Schalk, Werner J Heinz, et al.
Mycoses|March 17, 2025
Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment OptionSibylle C Mellinghoff, Martin Thelen, Michael von Bergwelt-Baildon, et al.
Leukemia|December 23, 2021
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Leonie Mayer, et al.
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
Pageof 8